Member Contact: Paul Brennan
Position: Chief Executive Officer
Industry: Medtech & Digital
"PolyNovo (PNV) is the developer and owner of unique Biodegradable Polymers (NovoSorb) used in regenerative medical applications. NovoSorb™ can be utilised as a Foam, Thermoplastic, Filament, Injection Moulded Form and In Situ two part setting filler.
The first commercial product range is a Dermal Matrix used in surgical wound repair and full thickness burn treatment. We are developing further products in
• Breast Sling,
• Hernia Repair,
• Pelvic Floor Repair,
• Breast Reconstruction.
Clinical trials, of the Dermal Matrix, are in progress in Toulon (France), Melbourne and Adelaide.
PolyNovo is based in Port Melbourne with a Class 7 Cleanroom manufacturing facility, with TÜV-SÜD accreditation and EN ISO 13485 (2012)
Australian Securities Exchange (ASX) Code: PNV"